Asensus jumps on sale of robotic surgical system
** Shares of medical device maker Asensus Surgical ASXC.A
rise ~4.3% to 24 cents in premarket trading
** Co says it sold a Senhance Surgical System to its
distribution partner
** Senhance uses augmented intelligence and machine learning
to improve surgical performance
** ASXC says the system will be placed in a pediatric
hospital in the Commonwealth of Independent States region
** Up to last close, stock down 39.5% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on Asensus Surgical
See all newsBrief: Asensus Surgical Receives FDA 510(K) Clearance For Senhance Surgical System In Urology
Brief: Asensus Surgical Inc Announces Non-Binding Acquisition Proposal And Exclusivity Arrangement With KARL STORZ SE & Co. KG
Brief: Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
Brief: Asensus Announces Sale Of Senhance Robotic System In Romania
Asensus jumps on sale of robotic surgical system